Matthew W. Emmens
2010
In 2010, Matthew W. Emmens earned a total compensation of $14.9M as Former Chairman, President CEO at Vertex Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,931,638 |
|---|---|
| Option Awards | $8,998,774 |
| Salary | $1,129,192 |
| Stock Awards | $1,842,727 |
| Other | $9,829 |
| Total | $14,912,160 |
Emmens received $9M in option awards, accounting for 60% of the total pay in 2010.
Emmens also received $2.9M in non-equity incentive plan, $1.1M in salary, $1.8M in stock awards and $9.8K in other compensation.
Rankings
In 2010, Matthew W. Emmens' compensation ranked 141st out of 10,439 executives tracked by ExecPay. In other words, Emmens earned more than 98.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 141 out of 10,439 | 99th |
Division Manufacturing | 46 out of 3,838 | 99th |
Major group Chemicals And Allied Products | 10 out of 921 | 99th |
Industry group Drugs | 7 out of 680 | 99th |
Industry Pharmaceutical Preparations | 6 out of 481 | 99th |
Source: SEC filing on April 4, 2013.
Emmens' colleagues
We found five more compensation records of executives who worked with Matthew W. Emmens at Vertex Pharmaceuticals in 2010.
2010
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2010
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2010
Kenneth Boger
Vertex Pharmaceuticals
Chief Legal Officer
2010
Amit Sachdev
Vertex Pharmaceuticals
Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada
2010
Nancy Wysenski
Vertex Pharmaceuticals